For the fifth consecutive year, Roche (SIX: RO, ROG; OTCQX: RHHBY) has been recognised by the Dow Jones Sustainability Index (DJSI) as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry, based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as benchmark for investors who integrate sustainability considerations into their portfolios.
"We are proud to be recognised as the most sustainable company in our peer group worldwide. We will continue our efforts to do business in a way that contributes to help patients and society through developing new medicines and diagnostics," said
This year's DJSI assessment emphasised a number of Roche's efforts, such as how the company manages innovation, especially the development of new medical products that create value, management of the supply chain and engagement with stakeholders. Roche's programmes on managing talent and developing future leaders received the highest points, as did customer relationship management. Roche also scored highly in the areas of marketing practices, human rights, environmental reporting and its contribution to improve health outcomes.
In 2009 Roche introduced a number of five-year corporate goals, using Key Performance Indicators to measure progress. Among these, Roche introduced a diversity objective to increase the percentage of women in key positions by at least 50 percent, as well as an energy-efficiency goal of reducing energy consumption and increasing energy efficiency by 10 percent by the end of 2014. Roche is well on track with these and other goals.
The Dow Jones Sustainability(TM) Indices are maintained collaboratively by S&P Dow Jones Indices and
Most Popular Stories
- 15 Myths That Could Ruin Your Hispanic Ad Campaign
- Bitcoin Clones Lurch Onto Financial Scene
- General Motors Names Mary Barra as First Female CEO
- AIG to Create 230 Jobs in Charlotte
- Clinton to Keynote Annual Simmons Leadership Conference
- Pacific Trade Pact Delay Hinders U.S. Pivot to Asia
- Californians Want to Legalize Marijuana
- Scripps Shares Rise on Reported Bid Talks
- Russia Says Nyet to Canada North Pole Claim
- Budget Deal Sets Off Grumbles in Both Houses